Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2021 · 10-Q
Revenue$315.79M$315.79M−38.8% vs Q1 2020 Net Income$65.40M$65.40M+17.0% vs Q1 2020 EPS Diluted$4.01$4.01+18.6% vs Q1 2020 Operating Income$80,441,000+1.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived$89,022,000+28.2% Margins · derivedOperating margin25.5%+10.1 pt vs Q1 2020
Net margin20.7%+9.9 pt vs Q1 2020
ended Mar 31, 2021 · filed Apr 30, 2021 · 30 d after period end